These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 29685843)

  • 41. [Allogeneic hematopoietic stem cell transplantation and treatment with CAR-T cells - identification of psycho-social vulnerability factors: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Polomeni A; Ainaoui M; Berr A; de Bentzman N; Denis M; Friser V; Magro L; Yakoub-Agha I
    Bull Cancer; 2024 Feb; 111(2S):S67-S77. PubMed ID: 37169605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In Vitro Differentiation of T Cell: From CAR-Modified T-iPSC.
    Ueda T; Kaneko S
    Methods Mol Biol; 2019; 2048():85-91. PubMed ID: 31396933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Renal failure after allogeneic hematopoietic stem cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].
    Detrait M; de Berranger E; Dulery R; Ménard AL; Thépot S; Toprak SK; Turlure P; Yakoub-Agha I; Guillaume T
    Bull Cancer; 2020 Jan; 107(1S):S28-S35. PubMed ID: 31303250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CAR T-cells: A John von Neumann legacy?
    Quesnel B
    Curr Res Transl Med; 2018 May; 66(2):35-36. PubMed ID: 29685844
    [No Abstract]   [Full Text] [Related]  

  • 45. [Management of graft failure and erythroblastopenia in patients undergoing allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Cornillon J; Sicre de Fontbrune F; Chantepie S; Coiteux V; Gauthier J; Masouridi-Levrat S; Pochon C; Terriou L; Yakoub-Agha I; Dalle JH
    Bull Cancer; 2016 Nov; 103(11S):S248-S254. PubMed ID: 27810141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Allogeneic hematopoietic cell transplantation for Hodgkin's disease, mantle cell lymphoma and other rare entities: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
    Bull Cancer; 2017 Dec; 104(12S):S112-S120. PubMed ID: 29173978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Alsuliman T; Aubrun C; Bay JO; Beguin Y; Bigenwald C; Brissot E; Chalandon Y; Chevallier P; Pagliuca S; Magro L; Srour M
    Bull Cancer; 2024 Apr; ():. PubMed ID: 38631984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Allogeneic haematopoietic cell transplantation for indolent lymphomas: Guidelines from the Francophone Society Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
    Bull Cancer; 2017 Dec; 104(12S):S121-S130. PubMed ID: 29173973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Harmonization of data coding in post-transplant follow-up - "GVHD, complications and additional treatments": Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Cornillon J; Detrait M; Karam M; Le Bars L; Meziane Y; Pereira M; Richard-Leveille S; Marion S; Leroux S; Coiteux V; Raus N; Seris S; Guyotat D; Yakoub-Agha I; Laurent N
    Bull Cancer; 2019 Jan; 106(1S):S71-S82. PubMed ID: 30448095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishment of a cell processing laboratory to support hematopoietic stem cell transplantation and chimeric antigen receptor (CAR)-T cell therapy.
    Mukherjee S; Reddy O; Panch S; Stroncek D
    Transfus Apher Sci; 2021 Feb; 60(1):103066. PubMed ID: 33472742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.
    Tomuleasa C; Fuji S; Berce C; Onaciu A; Chira S; Petrushev B; Micu WT; Moisoiu V; Osan C; Constantinescu C; Pasca S; Jurj A; Pop L; Berindan-Neagoe I; Dima D; Kitano S
    Front Immunol; 2018; 9():239. PubMed ID: 29515572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [National patient follow-up care logbook: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Guenounou S; Aubrun C; Brancillon N; Bemben D; Chauvel C; Hounmenou N; Magro L; Porcheron S; Poullain M; De Bentzmann N; Gargallo G; Le Bars L; Mercier L; Yakoub-Agha I; Paul F
    Bull Cancer; 2021 Dec; 108(12S):S87-S89. PubMed ID: 34756418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
    Bull Cancer; 2017 Dec; 104(12S):S106-S111. PubMed ID: 29169650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Rubio MT; Varlet P; Allain V; Ballot C; Cuffel A; Deschamps M; Ferrand C; Foguenne J; Forcade E; Huynh A; Guihot A; Latouche JB; Lemarie C; Martinroche G; Morin F; Nguyen S; Schmit K; Servais S; Simonetta F; Yakoub-Agha I; Caillat Zucman S
    Bull Cancer; 2021 Dec; 108(12S):S53-S64. PubMed ID: 34253335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia.
    Liu J; Zhang X; Zhong JF; Zhang C
    Immunotherapy; 2017 Oct; 9(13):1115-1125. PubMed ID: 29032733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [General and ethical considerations for the informed consent process: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Thibert JB; Polomeni A; Yakoub-Agha I; Bordessoule D
    Bull Cancer; 2016 Nov; 103(11S):S207-S212. PubMed ID: 27855949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chimeric Antigen Receptor T-Cell Therapy: What the Neuroradiologist Needs to Know.
    Valand HA; Huda F; Tu RK
    AJNR Am J Neuroradiol; 2019 May; 40(5):766-768. PubMed ID: 31048298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy.
    Liu X; Zhao Y
    Curr Res Transl Med; 2018 May; 66(2):39-42. PubMed ID: 29691200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC].
    Bonnin A; Terriou L; Beuvon C; Tudesq JJ; Puyade M; Pugnet G; Maria A; Llorente CC; Lansiaux P; Cacciatore C; Badoglio M; Yakoub-Agha I; Farge-Bancel D; Marjanovic Z
    Bull Cancer; 2024 Feb; 111(2S):S84-S95. PubMed ID: 37845095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Unrelated donor selection for allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Cornillon J; Crocchiolo R; Dubois V; Guidicelli G; Jorge-Cordeiro D; Meunier MC; Michiels S; Timmermans A; Villemonteix J; Yakoub-Agha I; Ahmad I
    Bull Cancer; 2024 Feb; 111(2S):S1-S13. PubMed ID: 37690877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.